OPKO Health, Inc.
(NASDAQ : OPK)

( )
OPK After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.50%163.450.7%$1097.89m
MRKMerck & Co., Inc. 1.10%76.410.7%$1035.99m
LLYEli Lilly & Co. 7.28%232.901.1%$961.74m
PFEPfizer Inc. 0.44%39.220.9%$930.12m
ABBVAbbVie, Inc. 0.63%114.721.9%$722.71m
BMYBristol-Myers Squibb Co. 0.90%65.851.0%$630.59m
AZNAstraZeneca Plc 0.76%58.421.2%$392.39m
OGN 0.98%29.790.0%$271.28m
ORPHOrphazyme A/S 9.54%8.150.0%$230.74m
GSKGlaxoSmithKline Plc -0.33%39.720.2%$182.79m
NVSNovartis AG 0.07%92.450.2%$180.25m
NOVNNovan, Inc. 1.91%10.695.8%$134.96m
CVACCureVac NV 5.01%59.760.0%$116.54m
CNSTConstellation Pharmaceuticals, Inc. 0.12%33.800.0%$110.91m
RPRXRoyalty Pharma Plc 1.99%43.030.2%$106.04m

Company Profile

OPKO Health, Inc., is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.